COMMUNIQUÉS West-GlobeNewswire

ContraFect to Present at Piper Jaffray Health Care Conference
19/11/2018
YONKERS, N.Y., Nov. 19, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX) , a clinical-stage biotechnology company focused on the discovery and development of protein and antibody therapeutics for life- [...]
Avivagen’s Asian partner UNAHCO continues to ramp-up use of OxC-beta™ Livestock with new large order
19/11/2018
OTTAWA, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Avivagen Inc. (TSXV:VIV) (“Avivagen”), is pleased to announce that its partner in the Philippines, UNAHCO, has purchased 2 metric tonnes of OxC-beta™ Livestock. This follows a 2 [...]
BriaCell to Present Updated Clinical Data Including Early Safety Data in KEYTRUDA® Combination Study and Positive Phase IIa Monotherapy Efficacy Data at 2018 San Antonio Breast Cancer Symposium
19/11/2018
Positive proof of concept data with Bria-IMT™ Monotherapy will highlight potent anti-tumor activity and an excellent safety profile for Bria-IMT™ in advanced breast cancer. Patient dosing is ongoing in a combination [...]
Evolus Receives Conditional FDA Acceptance of Jeuveau™ Brand Name
19/11/2018
Less Than 90 days to FDA Action Date for Jeuveau IRVINE, Calif., Nov. 19, 2018 (GLOBE NEWSWIRE) -- Evolus, Inc. (NASDAQ: EOLS), a company dedicated to aesthetic medicine, today announced the conditional acceptance from [...]
Arrayit Corporation Announces Allergy Testing Agreement with Sutter Health
19/11/2018
Sunnyvale, Nov. 19, 2018 (GLOBE NEWSWIRE) -- Arrayit Corporation (OTC: ARYC ), a life sciences and personalized medicine company, announces an allergy testing agreement with Northern California healthcare leader Sutter [...]
Transactions under Novozymes’ stock buyback program
19/11/2018
Please read the full announcement in the attached PDF Attachment 2018_64_Stock_Buybackprogram_EN
Active Biotech's election committee appointed
19/11/2018
PRESS RELEASE In accordance with a decision made by the Annual General Meeting held on May 17, 2018, the Election Committee shall comprise the representatives for the three largest shareholders by votes, as per end of [...]
Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech
19/11/2018
PRESS RELEASE Immunocore to co-develop IMC-C103C, a T cell redirecting bi-specific biologic, with Genentech First-in-human clinical trial of IMC-C103C scheduled to commence in 2019 in multiple solid tumour indications ( [...]
GENFIT ANNOUNCES PLANS TO CONDUCT REGISTERED PUBLIC OFFERING IN THE UNITED STATES
19/11/2018
FOR IMMEDIATE RELEASE GENFIT ANNOUNCES PLANS TO CONDUCT REGISTERED PUBLIC OFFERING IN THE UNITED STATES Lille (France), Cambridge (Massachusetts, United States), November 19, 2018 - GENFIT SA (Euronext: GNFT), a French [...]
GENFIT ANNONCE SON INTENTION DE PROCÉDER À UNE OFFRE AU PUBLIC AUX ÉTATS-UNIS
19/11/2018
POUR DIFFUSION IMMÉDIATE GENFIT ANNONCE SON INTENTION DE PROCÉDER À UNE OFFRE AU PUBLIC AUX ÉTATS-UNIS Lille (France), Cambridge (Massachusetts, États-Unis), le 19 novembre 2018 - GENFIT SA (Euronext : GNFT), une [...]
Sonoma Pharmaceuticals Announces Pricing of Public Offering of Units
17/11/2018
PETALUMA, Calif., Nov. 17, 2018 (GLOBE NEWSWIRE) -- Sonoma Pharmaceuticals, Inc. (Nasdaq: SNOA) today announced the pricing of a “best efforts” public offering of units consisting of one share of common stock, together [...]
Teligent, Inc. Receives Notification of Deficiency From NASDAQ Related to the Delayed Filing of Form 10-Q
16/11/2018
BUENA, N.J., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), on November 13, 2018 received a standard notice from NASDAQ stating that, as a result of not having timely filed its quarterly report on Form [...]
FDA approves Novartis drug Promacta® for first-line SAA and grants Breakthrough Therapy designation for additional new indication
16/11/2018
Promacta receives FDA approval for first-line treatment of severe aplastic anemia (SAA) and Breakthrough Therapy designation for low platelet counts in people exposed to radiation Approval based on compelling benefit [...]
CareDx Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
16/11/2018
BRISBANE, Calif., Nov. 16, 2018 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics company focused on the discovery, development and commercialization of clinically differentiated, high-value [...]
Ziopharm Oncology Provides Controlled IL-12 Update with Positive Data from Phase 1 Trial Presented at Annual Meeting of the Society for Neuro-Oncology
16/11/2018
Ad-RTS-hIL-12 plus 20mg veledimex (Controlled IL-12) determined to be preferred dosing with low-dose steroids to treat adult patients with recurrent glioblastoma Median overall survival for Ad-RTS-hIL-12 plus veledimex [...]
Golden Leaf Closes C$7.9 million Private Placement of Unsecured Convertible Subordinated Debenture Units
16/11/2018
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES TORONTO, Nov. 16, 2018 (GLOBE NEWSWIRE) -- Golden Leaf Holdings Ltd. (the “Company”, “Golden Leaf” or the “Issuer”) (CSE: [...]
Letter to Shareholders to accompany recent proxy filing
16/11/2018
CEO to share a few thoughts in advance of the upcoming shareholder call on Monday, November 19 th at 5PM EST NEW HAVEN, Conn., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. ( NASDAQ: [...]
Flexion Therapeutics Named Top Place to Work for Second Consecutive Year by The Boston Globe
16/11/2018
BURLINGTON, Mass., Nov. 16, 2018 (GLOBE NEWSWIRE) -- Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it has been named one of the Top Places to Work in Massachusetts for the second consecutive year. The [...]
New Findings Presented at the VEITHsymposium Reiterate Consistent, Durable Outcomes in Complex Aortic Disease with Heli-FX(TM) Endoanchor(TM) System
16/11/2018
Three-Year Data from the ANCHOR Registry Reiterate Applicability in Patients with Hostile Aortic Neck Anatomies DUBLIN and NEW YORK - November 16, 2018 - Medtronic plc (NYSE:MDT) today announced new data on the Heli-FX( [...]

Pages